Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × Vorinostat × 30 days × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Anemia, Refractory, with Excess of Blasts 2 Uveal Melanoma 1 Recurrence 1 Oligodendroglioma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Lymphoma, Extranodal NK-T-Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 GATA2 Deficiency 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1 Anemia, Refractory 1

Interventions

Cyclophosphamide 8 fludarabine phosphate 5 fludarabine 5 Magnetic Resonance Spectroscopy 4 Filgrastim 4 Rituximab 3 Nivolumab 3 Gemcitabine 3 Etoposide 3 Doxorubicin 3 Vincristine 2 Vinblastine 2 Specimen Handling 2 Prednisone 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Lenalidomide 2 Granulocyte Colony-Stimulating Factor 2 Dacarbazine 2 Cisplatin 2 Brentuximab Vedotin 2 Bleomycin 2 treosulfan 1 tislelizumab 1 thymoglobulin 1 tafasitamab 1 ruxolitinib 1 relatlimab 1 polatuzumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡